SHINE to Supply UK Organization
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…
SHINE Technologies was awarded another Department of Energy’s Small Business Innovation Research Grant to help transform DOE-supported science and technology breakthroughs into viable products and services, creating a bridge between…
SHINE Technologies announced recently that it is entering into a supply agreement with GlyTherix Ltd, an Australian targeted-radiotherapy company specializing in developing antibody radiopharmaceuticals for solid tumors. According to a…
SHINE Technologies was awarded $32 million from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the organization announced today. According to a release, the funds will aid in the…
SHINE Technologies has partnered with Zeno Power, a developer of commercial Radioisotope Power Systems (RPSs), the company recently announced. According to a release, SHINE plans to provide Zeno with Strontium-90…
SHINE Technologies announced recently that it has partnered with Blue Earth Therapeutics, a company focused on developing innovative radiopharmaceuticals. According to a release, SHINE has provided to Blue Earth Therapeutics…
SHINE Technologies has signed a Memorandum of Understanding (MOU) with Orano to cooperate in the development of the U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from…